Financial Security Advisor’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Sell
1,627
-3,292
-67% -$3.36M 0.32% 37
2026
Q1
$4.52M Buy
4,919
+580
+13% +$588K 0.83% 25
2025
Q4
$4.66M Buy
4,339
+322
+8% +$308K 0.9% 23
2025
Q3
$3.07M Buy
4,017
+25
+0.6% +$18.6K 0.65% 26
2025
Q2
$3.11M Sell
3,992
-7
-0.2% -$5.44K 0.72% 25
2025
Q1
$3.3M Sell
3,999
-6
-0.1% -$4.99K 0.84% 24
2024
Q4
$3.09M Sell
4,005
-220
-5% -$182K 0.79% 23
2024
Q3
$3.74M Buy
4,225
+18
+0.4% +$16.2K 0.93% 21
2024
Q2
$3.81M Buy
4,207
+13
+0.3% +$10.4K 1.28% 17
2024
Q1
$3.26M Buy
4,194
+58
+1% +$41.3K 1.14% 19
2023
Q4
$2.41M Sell
4,136
-120
-3% -$70K 0.95% 21
2023
Q3
$2.29M Buy
+4,256
New +$2.19M 1.05% 18

Other funds holding LLY

Financial Security Advisor's LLY Position: Q2 2026 in Review

Financial Security Advisor reduced its Eli Lilly (LLY) stake by 67% in Q2 2026, selling an estimated $3.36M and leaving 1,627 shares worth $1.95M. The position accounts for 0.32% of the portfolio, ranked #37.

Financial Security Advisor first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.66M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Financial Security Advisor held 1,627 shares of Eli Lilly worth $1.95M as of Q2 2026.
  • Financial Security Advisor sold 3,292 Eli Lilly shares in Q2 2026, an estimated $3.36M.
  • Eli Lilly made up 0.32% of Financial Security Advisor's portfolio in Q2 2026, its #37 holding.
  • Financial Security Advisor first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • Financial Security Advisor's Eli Lilly position peaked at $4.66M in Q4 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Financial Security Advisor's 13F filing for Q2 2026, filed 11 Aug 2026.